Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says

NVO•2026-09-21

Pipeline and sales targets

Novo Nordisk aims to launch more than five blockbuster drugs by 2030 and to deliver more than 150 billion Danish crowns ($23 billion) in pipeline sales in 2035, its CEO Mike Doustdar said at a Capital Markets Day in London.

Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says

Pipeline and sales targets

Related News

FICO says UK credit card balances hit record £1,980 in July for second month

PRECIOUS-Gold slips as investors focus on Middle East, rate outlook

Tanker struck by projectile in Strait of Hormuz, two crew injured, UKMTO says

Morgan Stanley 1GT leads €49 million Series E funding round for Amber Electric

Hormuz shuttles keep oil flowing, but at a high cost: Bousso